Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

A pilot randomized controlled trial to improve geriatric frailty
Chan D-CD, Tsou H-H, Yang R-S, Tsauo J-Y, Chen C-Y, Hsiung CA, Kuo KN
BMC Geriatrics 2012 Sep 25;12(58):Epub
clinical trial
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Few randomized controlled trials (RCTs) report interventions targeting improvement of frailty status as an outcome. METHODS: This RCT enrolled 117 older adults (65 to 79 years of age) in Toufen, Taiwan who scored 3 to 6 on The Chinese Canadian Study of Health and Aging Clinical Frailty Scale Telephone Version and then score >= 1 on the Cardiovascular Health Study Phenotypic Classification of Frailty (CHS_PCF). With a two by two factorial design, subjects were randomly assigned to interventions (exercise and nutrition, EN, n = 55 or problem solving therapy, PST, n = 57) or controls (non-EN, n = 62 or non-PST, n = 60). Educational booklets were provided to all. EN group subjects received nutrition consultation and a thrice-weekly exercise-training program while PST group subjects received 6 sessions in 3 month. Subjects were followed at 3, 6, and 12 months. Primary outcome was improvement of the CHS_PCF by at least one category (from pre-frail to robust, or from frail to pre-frail or robust) from baseline assessments. One hundred and one completed final assessments. Intention-to-treat analysis with the generalized estimating equation model was applied with adjustment for time and treatment-by-time interactions. RESULTS: Mean age was 71.4 +/- 3.7 years, with 59% females. Baseline characteristic were generally comparable between groups. EN group subjects had a higher improvement rate on the primary outcome than non-EN group subjects (45% versus 27%, adjusted p = 0.008) at 3 months, but not 6 or 12 months. They also had more increase of serum 25(OH) vitamin D level (4.9 +/- 7.7 versus 1.2 +/- 5.4, p = 0.006) and lower percentage of osteopenia (74% versus 89% p = 0.042) at 12 months. PST group subjects had better improvement (2.7 +/- 6.1 versus 0.2 +/- 6.7, p = 0.035, 6-month) and less deterioration (-3.5 +/- 9.7 versus -7.1 +/- 8.7, p = 0.036, 12-month) of dominant leg extension power than non-PST subjects. Some secondary outcomes were also improved in control groups (non-EN or non-PST). No adverse effects were reported. CONCLUSIONS: The three-month EN intervention resulted in short-term (3-month) frailty status improvement and long-term effect on bone mineral density and serum vitamin D (12-month) among Taiwanese community-dwelling elders. The effect of PST was less pronounce. TRIAL REGISTRATION: ClinicalTrials.gov EC0970301.

Full text (sometimes free) may be available at these link(s):      help